Human Epidermal Growth Factor Receptor 2 Testing by Fluorescent In Situ Hybridization: Positive or Negative? American Society of Clinical Oncology/College of American Pathologists Guidelines 2007, 2013, and 2018
Arch Pathol Lab Med
.
2019 Apr;143(4):412-413.
doi: 10.5858/arpa.2018-0905-LE.
Epub 2019 Jan 3.
Authors
Ciara Murray
1
,
Clare D'Arcy
1
,
Giuseppe Gullo
1
,
Louise Flanagan
1
,
Cecily M Quinn
1
2
Affiliations
1
1 St Vincent's University Hospital, Dublin, Ireland.
2
2 University College Dublin, Dublin, Ireland.
PMID:
30605368
DOI:
10.5858/arpa.2018-0905-LE
No abstract available
Publication types
Letter
Comment
MeSH terms
Biomarkers, Tumor
Breast Neoplasms*
Humans
In Situ Hybridization, Fluorescence
Medical Oncology
Pathologists
Receptor, ErbB-2 / genetics
Substances
Biomarkers, Tumor
ERBB2 protein, human
Receptor, ErbB-2